BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27051737)

  • 1. Aggressive CD8(+) epidermotropic cutaneous T-cell lymphoma associated with homozygous mutation in SAMHD1.
    Merati M; Buethe DJ; Cooper KD; Honda KS; Wang H; Gerstenblith MR
    JAAD Case Rep; 2015 Jul; 1(4):227-9. PubMed ID: 27051737
    [No Abstract]   [Full Text] [Related]  

  • 2. SAMHD1 compound heterozygous rare variants associated with moyamoya and mitral valve disease in the absence of other features of Aicardi-Goutières syndrome.
    Karla AR; Pinard A; Boerio ML; Hemelsoet D; Tavernier SJ; De Pauw M; Vereecke E; Fraser S; Bamshad MJ; Guo D; Callewaert B; Milewicz DM
    Am J Med Genet A; 2024 Apr; 194(4):e63486. PubMed ID: 38041217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation.
    Henrickson M; Wang H
    Clin Rheumatol; 2017 Jun; 36(6):1445-1451. PubMed ID: 28289923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aicardi-Goutières syndrome and systemic lupus erythematosus (SLE) in a 12-year-old boy with SAMHD1 mutations.
    Ramantani G; Häusler M; Niggemann P; Wessling B; Guttmann H; Mull M; Tenbrock K; Lee-Kirsch MA
    J Child Neurol; 2011 Nov; 26(11):1425-8. PubMed ID: 21670392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans.
    White TE; Brandariz-Nuñez A; Martinez-Lopez A; Knowlton C; Lenzi G; Kim B; Ivanov D; Diaz-Griffero F
    Hum Mutat; 2017 Jun; 38(6):658-668. PubMed ID: 28229507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Autoimmune Disorders in Aicardi-Goutières Syndrome.
    Samanta D; Ramakrishnaiah R; Crary SE; Sukumaran S; Burrow TA
    Pediatr Neurol; 2019 Jul; 96():37-39. PubMed ID: 30898416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response.
    Rice GI; Bond J; Asipu A; Brunette RL; Manfield IW; Carr IM; Fuller JC; Jackson RM; Lamb T; Briggs TA; Ali M; Gornall H; Couthard LR; Aeby A; Attard-Montalto SP; Bertini E; Bodemer C; Brockmann K; Brueton LA; Corry PC; Desguerre I; Fazzi E; Cazorla AG; Gener B; Hamel BC; Heiberg A; Hunter M; van der Knaap MS; Kumar R; Lagae L; Landrieu PG; Lourenco CM; Marom D; McDermott MF; van der Merwe W; Orcesi S; Prendiville JS; Rasmussen M; Shalev SA; Soler DM; Shinawi M; Spiegel R; Tan TY; Vanderver A; Wakeling EL; Wassmer E; Whittaker E; Lebon P; Stetson DB; Bonthron DT; Crow YJ
    Nat Genet; 2009 Jul; 41(7):829-32. PubMed ID: 19525956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells.
    Kodigepalli KM; Li M; Liu SL; Wu L
    Cell Cycle; 2017 Jan; 16(2):179-188. PubMed ID: 27929746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-stranded nucleic acids promote SAMHD1 complex formation.
    Tüngler V; Staroske W; Kind B; Dobrick M; Kretschmer S; Schmidt F; Krug C; Lorenz M; Chara O; Schwille P; Lee-Kirsch MA
    J Mol Med (Berl); 2013 Jun; 91(6):759-70. PubMed ID: 23371319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAMHD1 associates with inflammation and vasculitis in paediatric-onset systemic lupus erythematosus.
    Zhao X; Li C; Li S; Zhang J; Kuang W; Deng J; Tan X; Li C; Wang J
    Clin Exp Rheumatol; 2022 Sep; 40(9):1801-1807. PubMed ID: 35579088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations.
    Goncalves A; Karayel E; Rice GI; Bennett KL; Crow YJ; Superti-Furga G; Bürckstümmer T
    Hum Mutat; 2012 Jul; 33(7):1116-22. PubMed ID: 22461318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAMHD1 prevents autoimmunity by maintaining genome stability.
    Kretschmer S; Wolf C; König N; Staroske W; Guck J; Häusler M; Luksch H; Nguyen LA; Kim B; Alexopoulou D; Dahl A; Rapp A; Cardoso MC; Shevchenko A; Lee-Kirsch MA
    Ann Rheum Dis; 2015 Mar; 74(3):e17. PubMed ID: 24445253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An Aicardi-Goutières syndrome associated with a quasi-Moyamoya by a biallelic mutation in SAMHD1].
    Barrit S
    Rev Med Brux; 2018; 39(3):155-160. PubMed ID: 29869477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Klotho attenuates IFNγ receptor signaling and SAMHD1 expression through blocking NF-κB translocation in glomerular mesangial cells.
    Tsai KD; Lee YC; Chen BY; Wu LS; Liang SY; Liu MY; Hung YW; Hsu HL; Chen PQ; Shieh JC; Lee YJ; Lin TH
    Int J Med Sci; 2023; 20(6):810-817. PubMed ID: 37213666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection.
    Berger A; Sommer AF; Zwarg J; Hamdorf M; Welzel K; Esly N; Panitz S; Reuter A; Ramos I; Jatiani A; Mulder LC; Fernandez-Sesma A; Rutsch F; Simon V; König R; Flory E
    PLoS Pathog; 2011 Dec; 7(12):e1002425. PubMed ID: 22174685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAMHD1-deficient fibroblasts from Aicardi-Goutières Syndrome patients can escape senescence and accumulate mutations.
    Franzolin E; Coletta S; Ferraro P; Pontarin G; D'Aronco G; Stevanoni M; Palumbo E; Cagnin S; Bertoldi L; Feltrin E; Valle G; Russo A; Bianchi V; Rampazzo C
    FASEB J; 2020 Jan; 34(1):631-647. PubMed ID: 31914608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Aicardi-Goutières syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures.
    Dale RC; Gornall H; Singh-Grewal D; Alcausin M; Rice GI; Crow YJ
    Am J Med Genet A; 2010 Apr; 152A(4):938-42. PubMed ID: 20358604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome.
    Ramantani G; Kohlhase J; Hertzberg C; Innes AM; Engel K; Hunger S; Borozdin W; Mah JK; Ungerath K; Walkenhorst H; Richardt HH; Buckard J; Bevot A; Siegel C; von Stülpnagel C; Ikonomidou C; Thomas K; Proud V; Niemann F; Wieczorek D; Häusler M; Niggemann P; Baltaci V; Conrad K; Lebon P; Lee-Kirsch MA
    Arthritis Rheum; 2010 May; 62(5):1469-77. PubMed ID: 20131292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early arteriopathy in Aicardi-Goutières syndrome 5. Case report and review of literature.
    Markovic I; Jocic-Jakubi B; Milenkovic Z
    Neuroradiol J; 2023 Dec; 36(6):740-745. PubMed ID: 36722173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi-Goutières syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1).
    Fuchs NV; Schieck M; Neuenkirch M; Tondera C; Schmitz H; Wendeburg L; Steinemann D; Elpers C; Rutsch F; König R
    Stem Cell Res; 2020 Mar; 43():101697. PubMed ID: 32062129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.